Emodin Inhibits Resistance to Imatinib by Downregulation of Bcr-Abl and STAT5 and Allosteric Inhibition in Chronic Myeloid Leukemia Cells.
Biol Pharm Bull
; 43(10): 1526-1533, 2020.
Article
in En
| MEDLINE
| ID: mdl-32999163
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Genes, abl
/
Emodin
/
Drug Resistance, Neoplasm
/
STAT5 Transcription Factor
/
Imatinib Mesylate
Limits:
Humans
Language:
En
Journal:
Biol Pharm Bull
Journal subject:
BIOQUIMICA
/
FARMACOLOGIA
Year:
2020
Type:
Article